Roche to buy part of LumiraDx for $295 million

Swiss drugmaker Roche announced that it has agreed to buy LumiraDx’s Point of Care diagnostics platform for about $295m. LumiraDx shares rose 20% to 76 cents in post-sale trading.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM